Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Collins

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|December 1, 2001
Enhancing cytotoxic T cell responses with altered-peptide ligandsR Zhao, E J Collins
Biopolymers|January 1, 1997
Peptide binding by class I and class II MHC moleculesM A Batalia, E J Collins
Immunological Reviews|August 13, 1998
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexesE J Collins, J A Frelinger
Steroids|March 1, 1973
Biologic activity of 16 -methyldichlorisone-17-butyrate in the rat and dogE J Collins, J Aschenbrenner, M Nakahama
Steroids|November 1, 1972
Biologic action of betamethasone 17,21-dipropionate in rat and dogE J Collins, J Aschenbrenner, M Nakahama
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognitionE J Collins, B L Booth, V Cerundolo
Schizophrenia Research|October 1, 1991
Measurement of therapeutic response in schizophrenia. A critical surveyE J Collins, T P Hogan, H Desai
Urology|August 1, 1977
Granular myoblastoma: perineal neoplasm of probable neural originA A Eason, J Karol, E J Collins
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1992
The pharmacoepidemiology of treatment-refractory schizophreniaE J Collins, T P Hogan, A G Awad
Proteins|January 1, 1991
Structure of ricin A-chain at 2.5 AB J Katzin, E J Collins, J D Robertus
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Archivum Immunologiae Et Therapiae Experimentalis|December 1, 2001
Enhancing cytotoxic T cell responses with altered-peptide ligandsR Zhao, E J Collins
Biopolymers|January 1, 1997
Peptide binding by class I and class II MHC moleculesM A Batalia, E J Collins
Immunological Reviews|August 13, 1998
Altered peptide ligand design: altering immune responses to class I MHC/peptide complexesE J Collins, J A Frelinger
Steroids|March 1, 1973
Biologic activity of 16 -methyldichlorisone-17-butyrate in the rat and dogE J Collins, J Aschenbrenner, M Nakahama
Steroids|November 1, 1972
Biologic action of betamethasone 17,21-dipropionate in rat and dogE J Collins, J Aschenbrenner, M Nakahama
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognitionE J Collins, B L Booth, V Cerundolo
Schizophrenia Research|October 1, 1991
Measurement of therapeutic response in schizophrenia. A critical surveyE J Collins, T P Hogan, H Desai
Urology|August 1, 1977
Granular myoblastoma: perineal neoplasm of probable neural originA A Eason, J Karol, E J Collins
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1992
The pharmacoepidemiology of treatment-refractory schizophreniaE J Collins, T P Hogan, A G Awad
Proteins|January 1, 1991
Structure of ricin A-chain at 2.5 AB J Katzin, E J Collins, J D Robertus
Pageof 5